View Post

From 1D to 5D: Data-driven Discovery of Whole-brain Dynamic Connectivity in fMRI Data

The analysis of functional magnetic resonance imaging (fMRI) data can greatly benefit from flexible analytic approaches. In particular, the advent of data-driven approaches to identify whole-brain time-varying connectivity and activity has revealed a number of interesting relevant variation in the data which, when ignored, can provide misleading information. In this lecture, I will provide a comparative introduction of a range …

View Post

Seeing the Sound: Optical Neural Interfaces for In Vivo Neuromodulation

Optogenetics has transformed experimental neuroscience by manipulating the activity of specific cell types with light, enabling in vivo neuromodulation with millisecond temporal resolution. Visible light with wavelengths between 430 nm and 640 nm is used for optogenetics, limiting penetration depth in vivo and resulting in an invasive fiber-tethered interface that damages the endogenous neural tissue and constrains the animal’s free …

View Post

Dan Rizzuto, Ph.D., CEO, Nia Therapeutics

As CEO, Dan Rizzuto gives firsthand account of how he started a new company from a research university. He shared lessons learned through this process, including being comfortable with uncertainties, being persistent, and remaining committed to the mission. Dan explains the importance of engaging with all stakeholders including IP, regulatory, clinical, products and reimbursements.

View Post

Eric Van Gieson, Ph.D., Biological Technologies Offices, DARPA

Eric Van Gieson provides valuable insights on his experiences working for a start-up and for the government. He brings a new perspective from the molecular discipline into the neurotech community. As a Program Manager for DARPA, Eric explains how DARPA helps shape the technology space, supports entrepreneurship, and works to ensure its investment has longevity.